Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
4DMT climbs as gene therapy patients keep jettisoning jabs
4DMT posted 60-week data on a gene therapy, providing evidence of durability in DME and sending its stock up more than 40% in premarket trading.
Nick Paul Taylor
Aug 1, 2025 5:35am
Cardiff posts updated colorectal cancer data, sinking stock
Jul 30, 2025 7:25am
Celcuity's breast cancer combo hits goals, teeing up FDA filing
Jul 28, 2025 6:00am
AstraZeneca's blockbuster contender hits phase 3 gMG goals
Jul 24, 2025 6:20am
Scancell picks winner from phase 2 cancer vaccine face-off
Jul 22, 2025 9:38am
Chasing Takeda, Alkermes reports phase 2 narcolepsy win
Jul 21, 2025 8:40am